(*2*)
(*5*) 
RapidEye
- Insulet (NASDAQ:PODD) stated it has obtained FDA clearance for its Omnipod 5 Automated Insulin Delivery, or AID, system for the remedy of type 2 diabetes in adults.
- The firm stated the clearance makes Omnipod 5 the one AID system authorized for each type 1 and type 2 diabetes administration.
